Corient Capital Partners’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$219K	Hold	930	–	–	0.02%	585
2022 Q2	$219K	Buy	+930	New	+$219K	0.02%	596